Natriumklorid Fresenius Kabi (Sodium Chloride)

Sodium chloride provides sodium and chloride ions that increase plasma osmolarity, drawing water into the vascular compartment. This expands intravascular volume and restores electrolyte concentrations, supporting blood pressure, tissue perfusion, and normal cellular functions.

The dose of Natriumklorid Fresenius Kabi is determined by the prescribing clinician based on the patient’s age, weight, clinical condition, and laboratory values. The healthcare professional calculates the appropriate volume and concentration required for safe and effective therapy.

Sodium chloride is a naturally occurring electrolyte, and limited data suggest it can be used when clinically indicated during pregnancy or lactation. However, the prescriber should evaluate the risk‑benefit profile for each individual, considering maternal and fetal health.

To order Natriumklorid Fresenius Kabi, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed), and import documentation.

Natriumklorid is a simple isotonic sodium chloride solution, whereas other electrolyte products may contain additional ions such as potassium, calcium, or glucose. The choice depends on the specific electrolyte deficits and clinical goals; Natriumklorid is preferred when only sodium and chloride replacement is required.

The product should be stored at 2‑8 °C, protected from light, and must not be frozen or shaken. Keep the vial in its original packaging until use and inspect for particulate matter or discoloration before administration.

Natriumklorid is administered intravenously, typically via a peripheral or central line. The infusion rate is set by the clinician, often using a calibrated infusion pump, and the solution is diluted or given undiluted according to the prescribed protocol.

Serious risks include severe hypernatremia, hyperchloremia, cardiac arrhythmias, pulmonary edema, and anaphylactic reactions. Prompt monitoring of serum electrolytes, fluid balance, and patient vital signs helps mitigate these risks.

Patients with known hypersensitivity to sodium chloride solutions, uncontrolled severe hypernatremia, or conditions where rapid fluid expansion is contraindicated (e.g., severe heart failure) should not receive Natriumklorid unless a clinician determines it is essential and safe.